We recently published a list of 8 Best Gene-Editing Stocks to Buy. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against other best gene-editing stocks to ...

A Nature analysis reveals the 25 highest-cited papers published this century and explores why they are breaking records.

Improvements in our understanding of the human genome, technological tools like artificial intelligence, and global ...

Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

Durham-based Precision BioSciences Inc. has received investigational new drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for PBGENE-HBV, an in vivo gene editing program designed ...

Lee said there is massive potential for mRNA-based therapeutics for neurological and other conditions. While the creation of gene-editing therapeutics has quickly advanced, delivery systems for ...

The 2006 paper `Using thematic analysis in psychology’ has been cited between 100,000 and 230,000 times, based on a range of ...

Nanotechnology offers a next-gen solution to plant genome editing challenges by enabling precise, efficient delivery of CRISPR, RNA, and DNA tools using nanoparticles like AuNPs, CNTs, and lipid ...

Another company looking to initiate clinical trials with an epigenetic-editor-based treatment for hepatitis is nChroma Bio.

Abu Dhabi Global Health Week (ADGHW) today honoured exceptional individuals and institutions from around the world whose ...

Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.

Advancements in mRNA technologies and LNP delivery systems have led to preclinical research into LNP-CRISPR-Cas9 mRNA-based therapeutics for solid ... specific targeting have created challenges for ...